跳至主要内容
临床试验/JPRN-UMIN000050760
JPRN-UMIN000050760已完成Unknown

A cross-sectional, web-based survey of physicians in breast cancer treatment to reveal the underserved patient population who do not receive CDK4/6 inhibitor plus endocrine therapy and to identify the challenges of the disparity in Japan - A cross-sectional, web-based survey of physicians in breast cancer treatment to reveal the underserved patient population who do not receive CDK4/6 inhibitor plus endocrine therapy and to identify the challenges of the disparity in Japan

Pfizer Japan Inc.0 个研究点目标入组 300 人开始时间: 2023年4月10日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
300